Threats in bioterrorism. I: CDC category A agents (Q34743491)

4 August 2017

1 reference

title

Threats in bioterrorism. I: CDC category A agents (English)

1 reference

4 August 2017

0 references

Robert G Darling

1

1 reference

4 August 2017

Christina L Catlett

series ordinal

2

1 reference

4 August 2017

Kermit D Huebner

series ordinal

3

1 reference

4 August 2017

David G Jarrett

series ordinal

4

1 reference

4 August 2017

1 May 2002

1 reference

Emergency medicine clinics of North America

4 August 2017

1 reference

4 August 2017

20

1 reference

4 August 2017

2

1 reference

4 August 2017

273-309

1 reference

Report on 640 victims of the Tokyo subway sarin attack

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2802%2900005-6

7 January 2021

Iraq's Biological Weapons

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2802%2900005-6

7 January 2021

Biological terrorism. Preparing to meet the threat

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2802%2900005-6

7 January 2021

Education is the key to defense against bioterrorism

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2802%2900005-6

7 January 2021

Anthrax as a potential biological warfare agent

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2802%2900005-6

7 January 2021

The specter of biological weapons

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2802%2900005-6

7 January 2021

Penicillin andB. anthracis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2802%2900005-6

7 January 2021

The Sverdlovsk anthrax outbreak of 1979

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2802%2900005-6

7 January 2021

Index case of fatal inhalational anthrax due to bioterrorism in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2802%2900005-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2802%2900005-6

7 January 2021

Death due to bioterrorism-related inhalational anthrax: report of 2 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2802%2900005-6

7 January 2021

Clinical presentation of inhalational anthrax following bioterrorism exposure: report of 2 surviving patients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2802%2900005-6

7 January 2021

Clinical and epidemiologic principles of anthrax

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2802%2900005-6

7 January 2021

Recognition and management of anthrax--an update

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2802%2900005-6

7 January 2021

Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2802%2900005-6

7 January 2021

Radiological changes in inhalation anthrax. A report of radiological and pathological correlation in two cases

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2802%2900005-6

7 January 2021

Observations on the prophylaxis of experimental pulmonary anthrax in the monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2802%2900005-6

7 January 2021

Anthrax vaccines: past, present and future

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2802%2900005-6

7 January 2021

Smallpox as a Biological Weapon

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2802%2900005-6

7 January 2021

Smallpox: clinical and epidemiologic features

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2802%2900005-6

7 January 2021

Large-scale quarantine following biological terrorism in the United States: scientific examination, logistic and legal limits, and possible consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2802%2900005-6

7 January 2021

The antibody response in man following infection with viruses of the pox group. III. Antibody response in smallpox

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2802%2900005-6

7 January 2021

Factors promoting acute and chronic diseases caused by yersiniae

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2802%2900005-6

7 January 2021

Radiographic manifestations of plaque in New Mexico, 1975-1980. A review of 42 proved cases

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2802%2900005-6

7 January 2021

Studies on Immunization Against Plague VIII. Study of Three Immunizing Preparations in Protecting Primates Against Pneumonic Plague

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2802%2900005-6

7 January 2021

Clinical recognition and management of patients exposed to biological warfare agents

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2802%2900005-6

7 January 2021

Pleuropulmonary Tularemia: its roentgen manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2802%2900005-6

7 January 2021

Radiographic spectrum of pleuropulmonary tularemia

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2802%2900005-6

7 January 2021

Detection of Francisella tularensis in biological specimens using a capture enzyme-linked immunosorbent assay, an immunochromatographic handheld assay, and a PCR.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2802%2900005-6

7 January 2021

Agglutination and ELISA methods in the diagnosis of tularemia in different clinical forms and severities of the disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2802%2900005-6

7 January 2021

Studies with tularemia vaccines in volunteers. IV. Brucella aggiutinins in vaccinated and nonvaccinated volunteers challenged with Pasteurella tularensis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2802%2900005-6

7 January 2021

A tickborne epidemic of tularemia

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2802%2900005-6

7 January 2021

Guideline for isolation precautions in hospitals. Part I. Evolution of isolation practices, Hospital Infection Control Practices Advisory Committee.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2802%2900005-6

7 January 2021

The efficacy of ciprofloxacin and doxycycline against experimental tularaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2802%2900005-6

7 January 2021

In vitro susceptibility ofFrancisella tularensis to fluoroquinolones and treatment of tularemia with norfloxacin and ciprofloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2802%2900005-6

7 January 2021

Preliminary report: isolation of Ebola virus from monkeys imported to USA.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2802%2900005-6

7 January 2021

Botulinum Toxin as a Biological Weapon: Medical and Public Health Management

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2802%2900005-6

7 January 2021

Laboratory findings in four cases of adult botulism suggest colonization of the intestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2802%2900005-6

7 January 2021

Botulism surveillance and emergency response. A public health strategy for a global challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2802%2900005-6

7 January 2021

10.1016/S0733-8627(02)00005-6

Identifiers

DOI

1 reference

release_q6f3k4ogpjhw3j5bwp63beneme

4 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/q6f3k4ogpjhw3j5bwp63beneme

24 November 2022

mapped directly with Wikidata item

1 reference